Physician profile
Katelyn Malbrecht
NPI 1861220063
$642.16
in general payments reported to CMS, 2019-2025
14 companies · $486 in 2025
The $486 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $156 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $542 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $542.21 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $99.95 | 2025 | |
| Caris Mpi, INC. | $99.87 | 2025 | Mi Cancer Seek |
| Merck Sharp & Dohme LLC | $79.91 | 2025 | Lynparza |
| Astrazeneca Pharmaceuticals LP | $77.41 | 2024-2025 | Lynparza |
| Tempus Ai, INC | $57.98 | 2024-2025 | Xt Cdx |
| Glaxosmithkline, LLC. | $33.10 | 2025 | Jemperli |
| Intuitive Surgical, INC. | $28.98 | 2024 | |
| Pfizer INC. | $27.65 | 2025 | |
| Abbvie INC. | $26.61 | 2024 | |
| Aspira Women'S Health INC | $26.26 | 2024 | Ova1 |
| Vertex Pharmaceuticals Incorporated | $25.44 | 2025 | |
| Myriad Genetic Laboratories, INC. | $21.97 | 2024 | Mychoice Cdx |
| Ethicon US, LLC | $19.69 | 2025 | Enseal, Evarrest |
| Smith+Nephew, INC. | $17.34 | 2025 | Pico 14, Renasys Touch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katelyn Malbrecht listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.